Nuzenio

Spero Therapeutics

Spero Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Equity awards for Spero Therapeutics (SPRO) chief medical officer - Stock TitanStock Titan · Thu, 06 Aug 2026 22:49:51 GMTSpero Therapeutics CMO Debra Zack files initial beneficial ownership statement - BitgetBitget · Thu, 06 Aug 2026 14:42:32 GMTSpero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Caledonian RecordCaledonian Record · Thu, 06 Aug 2026 06:41:31 GMTSPRO Q2'26 Earnings: EPS estimate is (0.17) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:30 GMTSpero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 20:02:28 GMTSpero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update ... - Caledonian RecordCaledonian Record · Tue, 04 Aug 2026 20:01:18 GMTSpero Therapeutics to discuss drug pipeline on Aug. 12 - Stock TitanStock Titan · Tue, 04 Aug 2026 20:01:00 GMTSpero Therapeutics (NASDAQ:SPRO) Stock Price Crosses Below Two Hundred Day Moving Average - What's Next? - MarketBeatMarketBeat · Tue, 04 Aug 2026 08:33:16 GMT

Timeline

Thu, 06 Aug 2026 22:49:51 GMTEquity awards for Spero Therapeutics (SPRO) chief medical officer - Stock Titan
Thu, 06 Aug 2026 14:42:32 GMTSpero Therapeutics CMO Debra Zack files initial beneficial ownership statement - Bitget
Thu, 06 Aug 2026 06:41:31 GMTSpero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Wed, 05 Aug 2026 11:00:30 GMTSPRO Q2'26 Earnings: EPS estimate is (0.17) USD - TradingView
Tue, 04 Aug 2026 20:02:28 GMTSpero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 - marketscreener.com
Tue, 04 Aug 2026 20:01:18 GMTSpero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update ... - Caledonian Record

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Spero Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.